A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.
about
Deletion of the two-component histidine kinase gene (CHK1) of Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro.Emerging drugs and vaccines for candidemiaCytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarminsComparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.Surface hydrophobicity changes of two Candida albicans serotype B mnn4delta mutants.Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherenceIn vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida speciesProtection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansMonoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosisIntravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasisInterplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Candida-specific antibodies during experimental vaginal candidiasis in mice.Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm.Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.A fungicidal monoclonal antibody protects against murine invasive candidiasis.Prospects for development of a vaccine to prevent and control vaginal candidiasis.Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasisIncreased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasisA small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.Candida albicans secreted aspartyl proteinases in virulence and pathogenesisVaccine and monoclonal antibody that enhance mouse resistance to candidiasisA monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases.Molecular recognition of Candida albicans (1->2)-β-mannan oligosaccharides by a protective monoclonal antibody reveals the immunodominance of internal saccharide residues.β-1,2-Mannosyltransferases 1 and 3 Participate in Yeast and Hyphae O- and N-Linked Mannosylation and Alter Candida albicans Fitness During Infection.Anticandidal immunity and vaginitis: novel opportunities for immune intervention.Adaptive immune responses to Candida albicans infection.Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis.Advances in combating fungal diseases: vaccines on the thresholdSynthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.Glycoconjugates and polysaccharides of fungal cell wall and activation of immune systemNDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test.Immunochemistry of pathogenic yeast, Candida species, focusing on mannan.Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens.Contribution of phospholipomannan to the surface expression of beta-1,2-oligomannosides in Candida albicans and its presence in cell wall extracts.Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans.Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.
P2860
Q24537152-F8B44FE9-D9DC-4CB0-A9D2-29878D565466Q26828993-FB34B175-F2F6-487F-8E1D-A97054093502Q27021956-9F7AE73D-F51E-4B8D-8BAB-9817DC0F0072Q30306740-110A1A5B-26E8-4D38-9F22-9DD7A064F7F4Q30436513-2C403EBF-0DB1-44C7-8037-972F7E32D04FQ30862390-A8D7E962-2318-4EDD-BD8D-A36E93B2D913Q33262661-7ADBEF01-8149-4165-97A7-BCA602BA3170Q34003695-CA687C14-10F9-4E3C-9444-77B33B51F8E8Q34004652-A95ACAF1-CFF0-4B8B-AE3B-1BF3D8EDB8ADQ34045440-EB11B076-F613-4E90-88A5-3E65C841774EQ34121150-FC721A1E-BE81-43D0-B5FE-C6BFC2C3D1E3Q34131697-9D19CA53-4423-4A70-8B23-CB5D77C53C99Q34131799-578D55B6-259A-4E50-966F-4CDDF0DB6E5EQ34142527-5EBDE154-215A-455E-BAE5-61969F88E3D2Q34259665-D404895C-2299-4470-BA4F-0DEA64022375Q34601994-7EC27DF8-40C1-4746-8300-CF7A1A0182DAQ34707478-D5CA96B8-7EAE-4141-A811-0CDAB4633E29Q34721320-B3CE17B9-8A6B-41E8-916A-3B00421280B5Q34761565-DD1CDD52-692C-4F5A-A430-6B4CC298592AQ35127891-A264DF69-9E40-4A24-BBB3-634E82462FC1Q35215948-C2124125-B916-4D64-9987-7926D5983D93Q35271053-EDF70222-6AEC-402E-AB67-5490E9CF5648Q35802339-D6D42299-4713-463E-8C7F-E2CB1B452527Q35879405-5172A553-9E81-408C-B3E2-D04841B6EDE6Q36002863-DD5BD380-66F5-4D35-BA96-B8557AF77FC7Q36044421-57EA107F-4508-4491-9CEA-2492CAC2F5DFQ36097307-BE535AE7-9413-4EB5-8975-30825C946AFDQ36147114-06642B3B-1BDA-486E-8C1F-096A39869D59Q36375275-54A41C58-3702-47CD-9698-FD7ABD915D76Q36406460-CEDEB22F-8FA4-4805-8564-FAEC7C3865F7Q36869958-22FEF64F-2D55-434B-9639-89A3B3FB0771Q36914682-960D568F-541A-4B77-B17A-5BEA64260440Q37159154-40E7DB13-BA09-4F04-A384-D978A6FCD86AQ37399422-591FE210-180C-4932-93AB-667177EAABF8Q37451649-C00E9A5A-FEDE-47DF-A62D-A65BD321D541Q38021261-B676DE29-7E96-413E-B2C0-4503F1325D98Q39519765-C9ED8A45-FD14-4042-B9CA-EE65CA793480Q39655968-84D71A98-FFA2-4B58-B152-487152C53114Q39671081-42E855A9-D86A-47DA-AB82-4DC58E89F1F7Q40089456-17BE9988-472A-4DD6-A6BE-9FE4F1144E97
P2860
A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@ast
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@en
type
label
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@ast
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@en
prefLabel
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@ast
A vaccine and monoclonal antib ...... da albicans vaginal infection.
@en
P2093
P2860
P1476
A vaccine and monoclonal antib ...... ida albicans vaginal infection
@en
P2093
P2860
P304
P407
P577
1998-12-01T00:00:00Z